NDC 23155-244-22 - Rizatriptan Benzoate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 23155-244
- Requested NDC
- 23155-244-22
- Package NDCs from labels
- 23155-244-22, 23155-244-45, 23155-244-46
- Manufacturer
- Heritage Pharmaceuticals Inc. | Emcure Pharmaceuticals Limited
- Effective date
- 2019-10-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| RIZATRIPTAN - Heritage Pharmaceuticals Inc. | Emcure Pharmaceuticals Limited | Heritage Pharmaceuticals Inc. | Emcure Pharmaceuticals Limited | 2019-10-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 23155-244-22 | EA - Each | 23155-244 | 828359cf-ecc9-40d1-b5cd-c99059b64fa6 | 1 | 2019-07-02 |
| 23155-244-46 | EA - Each | 23155-244 | bafdbe0b-7f45-42aa-8756-b37c3f65c235 | 1 | 2014-10-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| RIZATRIPTAN BENZOATE | ACTIVE INGREDIENT | WR978S7QHH | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| RIZATRIPTAN | ACTIVE MOIETY | 51086HBW8G | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aveeno Anti-Itch Concentrated | ZINC OXIDE, FERRIC OXIDE RED, AND PRAMOXINE HYDROCHLORIDE | Kenvue Brands LLC | 07f4d4d0-9cee-46c3-bc71-2024abd31c9e | 2025-10-29 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Premier Brands of America, Inc. | d3452573-f91f-f157-e053-2a95a90a1ad8 | 2025-10-27 | Warnings | 1K09F3G675 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Advanced Rx of Tennessee, LLC | 4137a02e-dcec-c14c-e063-6294a90aa44f | 2025-10-21 | Warnings, Adverse reactions | WR978S7QHH |
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | Creekwood Pharmaceuticals LLC | b517896b-167e-47d5-801d-7458f80e8ee2 | 2025-10-09 | Warnings, Adverse reactions | WR978S7QHH |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b52f29-c1a0-c673-e063-6294a90a9a7a | 2025-09-05 | Warnings | 1K09F3G675 |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b8003f-40be-3380-e063-6294a90a4f6b | 2025-09-05 | Warnings | 1K09F3G675 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Golden State Medical Supply, Inc. | 07605de4-bef2-70e8-e063-6394a90a33cc | 2025-08-20 | Warnings, Adverse reactions | WR978S7QHH |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | FSA Store Inc. | 3cd18f96-34f7-3f2c-e063-6294a90a3b7e | 2025-08-19 | Warnings | 1K09F3G675 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Aurobindo Pharma Limited | a8e37688-426c-4290-933d-54a34ae86000 | 2025-08-06 | Warnings, Adverse reactions | WR978S7QHH |
| Ferrum rosatum Graphites | FERRUM ROSATUM GRAPHITES | Uriel Pharmacy Inc. | 1a4ca338-eada-4c0f-8bce-480244940c89 | 2025-06-27 | Warnings | 1K09F3G675 |
| Aquavit | AQUAVIT | Uriel Pharmacy Inc. | c1c0887a-c388-c737-e053-2a95a90a076c | 2025-06-06 | Warnings | 1K09F3G675 |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b7eeeb-09ae-ffe6-e063-6294a90aba90 | 2025-05-07 | Warnings | 1K09F3G675 |
| RIZAFILM | RIZATRIPTAN BENZOATE | Gensco Laboratories LLC | fa32794e-d26d-e0bf-e053-6294a90abb0e | 2025-04-27 | Warnings, Adverse reactions | WR978S7QHH |
| RID Poison Ivy Rash Relief | CALAMINE AND ZINC OXIDE | Oystershell Consumer Health Inc. | 36c3af9a-2646-4427-e063-6394a90a2c5e | 2025-03-13 | Warnings | 1K09F3G675 |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Calamine | FERRIC OXIDE RED | Preferred Pharmaceuticals Inc. | 326f3d80-c1bf-4cf0-a662-58e02ed7ee67 | 2025-02-12 | Warnings, Adverse reactions | 1K09F3G675 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Proficient Rx LP | e7414f2d-d7cf-41e5-b457-f5850e8bb7a7 | 2025-02-01 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Asclemed USA, Inc. | 8fa794f4-4253-485d-b4ee-986178031339 | 2025-01-27 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate ODT | RIZATRIPTAN BENZOATE ODT | Direct Rx | db489d19-1509-c979-e053-2a95a90a4410 | 2025-01-22 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Direct_Rx | 05150193-cc2f-8b41-e063-6394a90a184c | 2025-01-22 | Warnings, Adverse reactions | WR978S7QHH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.